ID: ALA219908

Max Phase: Preclinical

Molecular Formula: C28H28IN3O3

Molecular Weight: 454.55

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cn(C/C=C\COC(c2ccccc2)(c2ccccc2)c2cc[n+](C)cc2)c(=O)[nH]c1=O.[I-]

Standard InChI:  InChI=1S/C28H27N3O3.HI/c1-22-21-31(27(33)29-26(22)32)17-9-10-20-34-28(23-11-5-3-6-12-23,24-13-7-4-8-14-24)25-15-18-30(2)19-16-25;/h3-16,18-19,21H,17,20H2,1-2H3;1H/b10-9-;

Standard InChI Key:  WHXRFJXFRHBCPC-KVVVOXFISA-N

Associated Targets(Human)

Thymidine kinase, mitochondrial 96 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Thymidine kinase 140 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Deoxynucleoside kinase 95 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 454.55Molecular Weight (Monoisotopic): 454.2125AlogP: 3.23#Rotatable Bonds: 8
Polar Surface Area: 67.97Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.31CX Basic pKa: CX LogP: 0.24CX LogD: 0.24
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.33Np Likeness Score: -0.21

References

1. Hernandez AI, Familiar O, Negri A, Rodríguez-Barrios F, Gago F, Karlsson A, Camarasa MJ, Balzarini J, Pérez-Pérez MJ..  (2006)  N1-substituted thymine derivatives as mitochondrial thymidine kinase (TK-2) inhibitors.,  49  (26): [PMID:17181158] [10.1021/jm0610550]

Source